We recently published a list of the 15 Best Growth Stocks to Buy for the Next 3 Years. In this article, we are going to take ...

Shares of Eli Lilly fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed ...

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

We recently published a list of the 10 Best Long-Term Dividend Stocks to Buy According to Billionaires. In this article, we ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company ...

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 inhibitor. The ...

The logos of Big Tech companies and key associations were featured prominently Monday at the White House Easter Egg Roll, offering an unprecedented scene and use of the grounds to promote private ...

Verzenio is helping the company expand its presence in the oncology field. Since the start of 2025, the stock has surged by nearly 8%. According to analysts, another promising area for Eli Lilly ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best American dividend stocks. Dividend-paying stocks have long benefited investors by ...